Fidelity SPDR Advertisement
Home > Boards > US OTC > Biotechs > Amarantus BioScience Holdings, Inc. (AMBS)

Amarantus BioScience (AMBS) <u>Price Target $2.25 By Fall</u>

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
BCNstocks Member Profile
 
Followed By 281
Posts 31,052
Boards Moderated 0
Alias Born 08/28/10
160x600 placeholder
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 8/19/2014 4:55:16 PM
EDISON EQUITY RESEARCH - AMARANTUS BIOSCIENCE "InvestorsHub NewsWire" - 8/19/2014 1:28:24 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/15/2014 4:14:47 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) "Edgar (US Regulatory)" - 8/14/2014 5:20:01 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/11/2014 5:15:32 PM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) "Edgar (US Regulatory)" - 8/8/2014 4:26:02 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/6/2014 4:05:37 PM
Initial Statement of Beneficial Ownership (3) "Edgar (US Regulatory)" - 8/1/2014 7:24:11 PM
Initial Statement of Beneficial Ownership (3) "Edgar (US Regulatory)" - 8/1/2014 4:15:58 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/28/2014 4:17:03 PM
Investor Updates on Growth Companies in the Small Cap Arena and Special Profile by SmallCapTraders.com "InvestorsHub NewsWire" - 7/16/2014 11:33:04 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/9/2014 4:53:54 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/7/2014 4:16:02 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/2/2014 5:14:24 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/24/2014 5:18:57 PM
Initial Statement of Beneficial Ownership (3) "Edgar (US Regulatory)" - 6/24/2014 5:01:01 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) "Edgar (US Regulatory)" - 6/20/2014 4:07:15 PM
Notice of Effectiveness (effect) "Edgar (US Regulatory)" - 6/18/2014 6:01:24 AM
Securities Registration Statement (s-1/a) "Edgar (US Regulatory)" - 6/3/2014 4:38:03 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/21/2014 4:04:36 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/20/2014 5:21:11 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) "Edgar (US Regulatory)" - 5/15/2014 5:08:33 PM
Securities Registration Statement (s-1) "Edgar (US Regulatory)" - 5/14/2014 5:10:22 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/29/2014 9:20:19 AM
Amended Annual Report (10-k/a) "Edgar (US Regulatory)" - 4/22/2014 6:01:33 AM
BCNstocks   Tuesday, 02/26/13 12:36:25 PM
Re: None
Post # of 108068 
Amarantus BioScience (AMBS) Price Target $2.25 By Fall 2013 Forecasts Biotech News Stock Review:

Amarantus BioScience (AMBS) Price Target $2.25 By Fall 2013 Forecasts Biotech News Stock Review. AMBS has a huge upside, look for this small biotech to take off soon on some very good news that we are hearing. By Fall today's share price will only be a distant memory!


http://biotechnewsstockreview.blogspot.com/2013/01/amarantus-bioscience-ambs-price-target.html



Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist